Search
News
Novel Immunotherapy Approach at Roswell Park Shows Promise in Metastatic Triple-Negative Breast Cancer
… led the study under the scientific leadership of Pawel Kalinski, MD, PhD, senior author of the paper, Chair of … Cancer Institute and U.S. Department of Defense, Dr. Kalinski directed earlier preclinical studies demonstrating … an easy-to-apply, short-term systemic treatment,” says Dr. Kalinski. CKM also may hold promise for treating other types …
News
Researchers Seek to Expand Immunotherapy Options for Patients with Advanced Breast and Colorectal Cancer
News
Roswell Park Clinical Trial Points Toward Promising New Therapy for Most Aggressive Type of Breast Cancer
… increases the risk of immune-related adverse events. Pawel Kalinski, MD, PhD , Professor of Immunology at Roswell Park, … increases the risk of immune-related adverse events. Pawel Kalinski, MD, PhD , Professor of Immunology at Roswell Park, …
News
New Immunotherapy Platform, Role of Stress in Cancer Highlight Roswell Park’s AACR 2022 Presentations
News
Roswell Park Oncologists and Scientists Bring Latest Research Findings to ASCO 2023
… in Hall A Shipra Gandhi, MD, is first author and Pawel Kalinski, PhD , is senior author on “ Phase IIa study of αDC1 … in Hall A Shipra Gandhi, MD, is first author and Pawel Kalinski, PhD , is senior author on “ Phase IIa study of αDC1 …
News